PYPL vs TRDA · P/E 7.9, rev $33.17B vs P/E 12, rev $210.8M
PayPal Holdings Inc (PYPL) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
PYPL currently screens at market cap $37.12B and trailing P/E 7.9. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the PYPL and TRDA stock pages for the full models.
Not investment advice.